Epstein-Barr virus-associated Hodgkin's disease following renal transplantation

Korean Journal of Internal Medicine

Volumn 21, Issue 1, 2006, Pages 46-49

  Choi, Jung Hye ^a   Ahn, Myung Ju ^a   Oh, Young Ha ^a   Han, Sang Woong ^a   Kim, Ho Jung ^a   Lee, Young Yeul ^a   Kim, In Soon ^a  

^a Hanyang University College of Medicine   (South Korea)

Author keywords

Hodgkin's disease; Post transplant lymphoproliferative disorder; Renal transplantation

Indexed keywords

BLEOMYCIN; CD30 ANTIGEN; CYCLOSPORIN; DACARBAZINE; DOXORUBICIN; MEMBRANE PROTEIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; VINBLASTINE;

ADULT; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER REGRESSION; CASE REPORT; CERVICAL LYMPHADENOPATHY; CHRONIC KIDNEY FAILURE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; EPSTEIN BARR VIRUS; HODGKIN DISEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE DEFICIENCY; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; LYMPH NODE BIOPSY; MALE;

EID: 33646690485     PISSN: 12263303     EISSN: None     Source Type: Journal    
DOI: 10.3904/kjim.2006.21.1.46     Document Type: Article

References (19)

1. Penn I. Cancers in renal transplant recipients. Adv Ren Replace Ther 7:147-156, 2000
2. Soler MJ, Puig JM, Mir M, Parrilla J, Pedro C, Salar A, Serrano S, Lloveras J. Posttransplant lymphoproliferative disease: treatment and outcome in renal transplant recipients. Transplant Proc 35:1709-1713, 2003
3. Shroff R, Rees L. The post-transplant lymphoproliferative disorder: a literature review. Pediatr Nephrol 19:369-377, 2004
4. Holmes RD, Sokol RJ. Epstein-Barr virus and post-transplant lymphoproliferative disease. Pediatr Transplant 6:456-464, 2002
5. Bedrossian J, Metivier F, Jaccard A, Binet I, Pruna A, Idatte JM. Hodgkin's disease and cadaveric renal transplantation. Transplant Proc 27:1783-1784, 1995
6. Bierman PJ, Vose JM, Langnas AN, Rifkin RM, Hauke RJ, Smir BN, Greiner TC. Hodgkin's disease following solid organ transplantation. Ann Oncol 7:265-270, 19515
7. Goyal RK, McEvoy L, Wilson DB. Hodgkin disease after renal transplantation in childhood. J Pediatr Hematol Oncol 18:392-395, 1956
8. Dharnidharka VR, Douglas VK, Hunger SP, Fennell RS. Hodgkin's lymphoma after post-transplant lymphoproliferative disease in a renal transplant recipient. Pediatr Transplant 8:87-90, 2004
9. Garnier JL, Lebranchu Y, Dantal J, Bedrossian J, Cahen R, Assouline D, Jaccard A, Fetissoff F, Moreau A, Martin X, Delsol G, Berger F, Touraine JL. Hodgkin's disease after transplantation. Transplantation 61:71-76, 1996
10. Pham PT, Wilkinson AH, Gritsch HA, Pham PC, Miller JM, Lassman CR, Danovitch GM. Monotherapy with the anti-CD20 monoclonal antibody rituximab in a kidney transplant recipient with posttransplant lymphoproliferative disease. Transplant Proc 34:1178-1181, 2002
11. Dharnidharka VR, Sullivan EK, Stablein DM, Tejani AH, Harmon WE. Risk factors for posttransplant lymphoproliferative disorder (PTLD in pediatric kidney transplantation a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). Transplantation 71:1065-1058, 2001
12. Penn I. Neoplastic complications of transplantation. Semin Respir Infect 8:233-239, 1993
13. Macsween KF, Crawford DH. Epstein-Barr virus-recent advances. Lancet Infect Dis 3:131-140, 2003
14. Savoie A, Perpete C, Carpentier L, Joncas J, Alfieri C. Direct correlation between the load of Epstein-Barr virus-infected lymphocytes in the peripheral blood of pediatric transplant patients and risk of lymphoproliferative disease. Blood 83:2715-2722, 1994
15. Haluska FG, Brufsky AM, Canellos GP. The cellular biology of the Reed-Sternberg cell. Blood 84:1005-1019, 1994
16. Gu SY, Huang TM, Ruan L, Miao YH, Lu H, Chu CM, Motz M, Wolf H. First EBV vaccine trial in humans using recombinant vaccinia virus expressing the major membrane antigen. Dev Biol Stand 84:171-177, 1995
17. Darenkov IA, Marcarelli MA, Basadonna GP, Friedman AL, Lorber KM, Howe JG, Crouch J, Bia MJ, Kliger AS, Lorber MI. Reduced Incidence of Epstein-Barr virus-associated posttransplant lymphoproliferative disorder using preemptive antiviral therapy Transplantation 64:848-852, 1997
18. Swinnen W, Mullen GM, Carr TJ, Costanzo MR, Fisher RI. Aggressive treatment for postcardiac transplant lymphoproliferation. Blood 86:3333-3340, 1995
19. Pham PT, Wilkinson AH, Gritsch HA, Pham PC, Miller JM, Lassman CR, Danovitch GM. Monotherapy with the anti-CD20 monoclonal antibody rituximab in a kidney transplant recipient with posttransplant lymphoproliferative disease. Transplant Proc 34:1178-1181, 2002